FPFS
ALXN

First Personal Financial Services’s Alexion Pharmaceuticals ALXN Stock Holding History

First Personal Financial Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13
Closed -$1K – 559
2019
Q4 		$1K Buy
+13
New +$1.39K ﹤0.01% 524
2019
Q3 		– Sell
-268
Closed -$35K – 795
2019
Q2 		$35K Sell
268
-18
-6% -$2.32K 0.01% 333
2019
Q1 		$39K Buy
286
+74
+35% +$9.2K 0.01% 312
2018
Q4 		$21K Sell
212
-21
-9% -$2.48K 0.01% 370
2018
Q3 		$32K Buy
233
+128
+122% +$16.1K 0.01% 345
2018
Q2 		$13K Sell
105
-156
-60% -$18.2K ﹤0.01% 459
2018
Q1 		$29K Buy
261
+93
+55% +$11.1K 0.01% 559
2017
Q4 		$20K Sell
168
-25
-13% -$3.04K ﹤0.01% 649
2017
Q3 		$27K Hold
193
– – 0.01% 533
2017
Q2 		$23K Buy
193
+10
+5% +$1.16K 0.01% 561
2017
Q1 		$22K Buy
183
+29
+19% +$3.74K 0.01% 549
2016
Q4 		$19K Buy
154
+18
+13% +$2.2K 0.01% 565
2016
Q3 		$17K Hold
136
– – 0.01% 468
2016
Q2 		$16K Buy
+136
New +$19.3K 0.01% 464

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

First Personal Financial Services's ALXN Position: Q1 2020 in Review

First Personal Financial Services sold out of Alexion Pharmaceuticals (ALXN) in Q1 2020, closing a stake of 13 shares — an estimated $1K sold.

First Personal Financial Services first reported a position in ALXN in Q2 2016 and held it in 14 quarters. The position peaked at $39K in Q1 2019. 654 funds tracked by Wall St. Rank hold ALXN as of Q1 2020.

  • First Personal Financial Services reported no remaining Alexion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • First Personal Financial Services sold 13 Alexion Pharmaceuticals shares in Q1 2020, an estimated $1K.
  • First Personal Financial Services first reported a position in Alexion Pharmaceuticals in Q2 2016 and held it in 14 quarters.
  • First Personal Financial Services's Alexion Pharmaceuticals position peaked at $39K in Q1 2019.
  • 654 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2020.

Based on First Personal Financial Services's 13F filing for Q1 2020, filed 22 Apr 2020.